NASDAQ:LTRN
Lantern Pharma Inc.
- Stock
Last Close
6.33
16/05 20:00
Market Cap
46.63M
Beta: 0.64
Volume Today
44.21K
Avg: 24.91K
PE Ratio
−3.14
PFCF: −3.29
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -1.73M - | -2.43M 40.65% | -5.91M 143.32% | -12.36M 109.25% | -14.26M 15.34% | -15.96M 11.93% | |
depreciation and amortization | -2.54K - | 1.63K 163.95% | 3.39K 108.24% | 6.76K 99.56% | 10.08K 49.11% | 174.84K 1,634.38% | |
deferred income tax | 251.65K - | -1.08M 529.90% | 112.56K 110.40% | ||||
stock based compensation | 185.60K - | 117.76K 36.55% | 1.19M 912.43% | 961.54K 19.35% | 1.19M 23.52% | ||
change in working capital | 271.84K - | 180.88K 33.46% | -939.06K 619.18% | 599.96K 163.89% | -611.86K 201.98% | 538.02K 187.93% | |
accounts receivables | -71.66K - | -158.40K 121.06% | -159.25K 0.54% | ||||
inventory | |||||||
accounts payables | 372.66K - | 117.17K 68.56% | 1.62M 1,284.42% | 580.36K 64.22% | -236.18K 140.70% | ||
other working capital | 271.84K - | -191.79K 170.55% | -1.06M 450.73% | -950.47K 10.01% | -1.03M 8.77% | 933.46K 190.29% | |
other non cash items | -251.65K - | 1.08M 529.90% | 90.66K 91.62% | 906.49K 899.88% | 902.12K 0.48% | ||
net cash provided by operating activities | -1.27M - | -2.13M 67.35% | -5.65M 165.59% | -10.59M 87.41% | -12.77M 20.54% | -14.35M 12.37% | |
investments in property plant and equipment | -5.72K - | -16.14K 182.26% | -15.50K 3.95% | -27.84K 79.65% | -18.73K 32.72% | ||
acquisitions net | 19.53B - | -179.27M 100.92% | 930.21M 618.89% | ||||
purchases of investments | -19.58M - | -3.91M 80.02% | -8.20M 109.48% | ||||
sales maturities of investments | 64.09K - | 4.12M 6,327.66% | 7.28M 76.83% | ||||
other investing activites | 5.34K - | -19.53B - | 179.27M 100.92% | -930.21M 618.89% | |||
net cash used for investing activites | 5.34K - | -5.72K 207.12% | -16.14K 182.26% | -19.53M 120,929.84% | 179.27K 100.92% | -930.21K 618.89% | |
debt repayment | -169.05K - | ||||||
common stock issued | 2.92M - | 23.56M 706.60% | 69.00M 192.91% | 299.79K 99.57% | |||
common stock repurchased | -939.67K - | -2.48M 164.17% | -500.00K 79.86% | ||||
dividends paid | |||||||
other financing activites | 535K - | 2.92K 99.45% | 277.29K 9,394.52% | -4.64M 1,774.87% | |||
net cash used provided by financing activities | 535K - | 2.92M 445.89% | 23.66M 710.30% | 63.42M 167.97% | -2.18M 103.44% | -500.00K 77.09% | |
effect of forex changes on cash | 1.07K - | -10.61K 1,091.31% | -28.46M 268,232.23% | ||||
net change in cash | -731.18K - | 786.87K 207.62% | 18.00M 2,187.20% | 33.30M 85.00% | -14.78M 144.39% | -15.81M 6.93% | |
cash at beginning of period | 1.18M - | 445.16K 62.16% | 1.23M 176.76% | 19.23M 1,460.78% | 52.52M 173.15% | 37.74M 28.14% | |
cash at end of period | 445.16K - | 1.23M 176.76% | 19.23M 1,460.78% | 52.52M 173.15% | 37.74M 28.14% | 21.94M 41.88% | |
operating cash flow | -1.27M - | -2.13M 67.35% | -5.65M 165.59% | -10.59M 87.41% | -12.77M 20.54% | -14.35M 12.37% | |
capital expenditure | -5.72K - | -16.14K 182.26% | -15.50K 3.95% | -27.84K 79.65% | -18.73K 32.72% | ||
free cash flow | -1.27M - | -2.13M 67.80% | -5.67M 165.64% | -10.61M 87.15% | -12.80M 20.63% | -14.37M 12.27% |
All numbers in USD (except ratios and percentages)